MRL/lpr mice
Original Article Therapeutic effect of dihydroartemisinin on lupus-prone MRL/lpr mice and its mechanism of action
6
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
14
Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
10
Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice
17
Reno protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr mice
11
Interferon gamma is required for lupus like disease and lymphoaccumulation in MRL lpr mice
9
Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice
14
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
13
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
11
Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway
8
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
8
Stochastic control of anti Sm autoantibodies in MRL/Mp lpr/lpr mice
8
Peroxynitrite Formation and Decreased Catalase Activity in Autoimmune MRL-lpr/lpr Mice
14
IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lprmice
17
Enhanced expression of interferon inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lprmice
9
Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus
11
Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity
14
Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
6
B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus
14
Establishment of Monoclonal Anti-Retroviral gp70 Autoantibodies from MRL/lpr Lupus Mice and Induction of Glomerular gp70 Deposition and Pathology by Transfer into Non-Autoimmune Mice
11